Vestal Point Capital LP cut its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 18.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 490,000 shares of the company’s stock after selling 110,000 shares during the period. Vestal Point Capital LP […]

Vestal Point Capital LP increased its position in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Free Report) by 4.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 930,000 shares of the company’s stock after buying an additional 40,000 shares during […]